Jon Hamilton
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
In 2014, Hamilton went to Liberia as part of the NPR team that covered Ebola. The team received a Peabody Award for its coverage.
Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.
Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans' social brains.
In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.
Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.
From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.
Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors. During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.
-
It feels simple: When we're thirsty, we drink. But the brain science explaining that simple decision turns out to be very complicated.
-
Under a proposal announced Tuesday, Medicare would cover the expensive and controversial Alzheimer's drug Aduhelm — but only for those participating in clinical trials.
-
Scientists have found a cluster of rhythmic brain cells in newborn mice that may explain why spoken languages around the world share a common tempo. -
A resurgence in COVID-19 cases is testing the endurance of health care workers who care for the sickest patients, most of whom are unvaccinated. -
Scientists may have learned why opioids depress breathing while relieving pain. The finding could lead to pain drugs that don't cause respiratory failure, the usual cause of death in opioid overdoses.
-
Scientists are beginning to understand how COVID can cause brain injuries. The virus can lead to a stroke, starve the brain of oxygen, cause inflammation brain and might infect and kill brain cells.
-
A new Alzheimer's drug isn't reaching many patients. Doctors say reasons include its high cost, and lingering questions about its effectiveness. -
People who sustain a concussion can develop an unusual hearing problem. Their ears work fine, but their brain struggles to process sounds.
-
Scientists have created detailed maps of the brain area that controls movement in mice, monkeys and people. The maps could help explain human ailments like Alzheimer's and Lou Gehrig's disease. -
Two scientists who helped explain how we sense temperature and touch have received the Nobel prize in physiology or medicine. Their research could lead to new pain treatments.
-
Intensive rehabilitative therapy that starts two to three months after a stroke may be key to helping the injured brain rewire, a new study suggests. That's later than covered by many insurance plans. -
The visual problem is usually treated in kids by temporarily covering the other eye with a patch. But that doesn't always work. Research now shows crucial brain rewiring can happen in adulthood, too.
